Fangping Chen
Impact in
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
Papers in
-
- RNA Interference and Gene Delivery 4
- Inflammasome and immune disorders 4
- DNA and Nucleic Acid Chemistry 4
- Epigenetics and DNA Methylation 3
- Hematology 12
- Acute Myeloid Leukemia Research 5
- Co-authors
- Xinyu Yang (5 shared papers)Ben Lü (5 shared papers)Haichao Wang (5 shared papers)Ben Lv (3 shared papers)Yiting Tang (6 shared papers)Xianzhong Xiao (5 shared papers)Wenjin Li (3 shared papers)Lin Li (1 shared paper)
- Journals
- Blood (2 papers)Thrombosis Research (2 papers)Scientific Reports (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fangping Chen
47 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Clinical Biochemistry 156
- Immunology 371
- Hematology 131
- Cancer Research 165
- Molecular Biology 634
Countries citing papers authored by Fangping Chen
This map shows the geographic impact of Fangping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangping Chen more than expected).
Fields of papers citing papers by Fangping Chen
This network shows the impact of papers produced by Fangping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangping Chen. The network helps show where Fangping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 244 | |
| 2 | 2014 | 130 | |
| 3 | 2015 | 101 | |
| 4 | 2019 | 93 | |
| 5 | 2009 | 72 | |
| 6 | 2007 | 69 | |
| 7 | 2013 | 68 | |
| 8 | 2013 | 52 | |
| 9 | 2018 | 45 | |
| 10 | 2009 | 42 | |
| 11 | 2017 | 39 | |
| 12 | 2019 | 33 | |
| 13 | 2020 | 30 | |
| 14 | 2019 | 29 | |
| 15 | 2009 | 25 | |
| 16 | 2013 | 24 | |
| 17 | 2014 | 23 | |
| 18 | 2013 | 22 | |
| 19 | 2019 | 20 | |
| 20 | 2021 | 16 |
About Fangping Chen
Fangping Chen is a scholar working on Molecular Biology, Hematology, Immunology, Cancer Research and Clinical Biochemistry, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), RNA Interference and Gene Delivery (4 papers), Inflammasome and immune disorders (4 papers), Immune Response and Inflammation (4 papers), Advanced Glycation End Products research (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Clinical Biochemistry (156 citations), Immunology (371 citations), Hematology (131 citations), Cancer Research (165 citations) and Molecular Biology (634 citations). Fangping Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xinyu Yang, Ben Lü, Haichao Wang, Ben Lv, Yiting Tang, Xianzhong Xiao, Wenjin Li, Lin Li, Xiaoye Cheng and Jin Liu. Their work appears in journals such as Blood, Thrombosis Research, Scientific Reports, Acta Biochimica et Biophysica Sinica and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.